Are Saudi Arabian Patients Willing to Be Deprescribed Their Medications? An Exploratory Study
DOI: https://doi.org/10.2147/ppa.s446873
2024-03-28
Patient Preference and Adherence
Abstract:Sultana A Alhurishi, 1 Munerah Fahad AlQahtani 2 1 Community Health Sciences Department, College of Applied Medical Sciences, King Saud University, Riyadh, Saudi Arabia; 2 Health Education Department, Muzahimiyah General Hospital, Riyadh, Saudi Arabia Correspondence: Sultana A Alhurishi, Email Purpose: Deprescribing is a complex process that requires active patient involvement, so the patient's attitude to deprescribing is crucial to its success. This study aimed to assess predictors of Saudi Arabian patients' willingness to deprescribe. Patients and Methods: In this cross-sectional study, adult patients from two hospitals in Riyadh completed a self-administered questionnaire gathering data on demographic information and the Arabic revised Patients' Attitudes Towards Deprescribing (rPATD) questions. Descriptive analysis and binary logistic regression were used to analyze the data. Results: A total of 242 patients were included (mean age 59.8 (SD 11.05) years, range 25– 87 years; 40% 60– 69 years; 54.1% female). The majority (90%) of participants were willing to have medications deprescribed. Willingness to deprescribe was significantly associated with the rPATD involvement factor (OR=1.866, 95% CI 1.177– 2.958, p=0.008) and the patient's perception of their health status (OR=2.08, CI=1.058– 4.119, p=0.034). Conclusion: The majority of patients were willing to have one or more medications deprescribed if recommended by their doctors. Patient perceptions about their own health and their involvement in deprescribing were important predictive factors that could shape counseling and education strategies to encourage deprescribing. Keywords: polypharmacy, deprescribing, Arabic, rPATD, Saudi Arabia, patients attitude and health services administration Polypharmacy describes the use of multiple medicines, 1 and its prevalence is increasing, especially in high-income countries. 2 However, polypharmacy, especially in older people, poses risks of adverse drug reactions, cognitive and physical changes, increased hospital admissions, and even death. 2 Deprescribing is an important concept that aims to reduce adverse outcomes due to polypharmacy. 2 Reeve et al 3 defined deprescribing as the process of withdrawal of an inappropriate medication, supervised by a healthcare professional, with the goal of managing polypharmacy and improving outcomes. Indeed, deprescribing has been shown to improve patient outcomes. 4 Given the other physiological and social changes faced by older adults, 5 reducing unnecessary prescribing in older patients might be a good way to improve their function and/or quality of life. 4,5 Effect of deprescribing varied by age. Reduction in mortality was noted among older people less than 80 years; however, mortality of those aged 80 years or more did not change. 6 Effective communication with patients is crucial to limit the withdrawal and relapse effects. 7 Patients' might depend on the clinician's decision and initiation to start deprescribing even though they were willing to cease medications. 7 Topics related to medication deprescribing include the body's response to medications, medication effectiveness, medication adverse effects and emerging treatment plan should be discussed thoroughly, especially with older aged patients. 8 Nevertheless, deprescribing faces several challenges including patient and physician attitudes to deprescribing as well as organizational factors. 9 From the physician perspective, deprescribing is challenged by a lack of knowledge about the deprescribing process, decisions and coordination of the process between patient, doctor, and pharmacist, and time constraints. 10 The prevalence of polypharmacy among Saudi older patients was 51.5%. 11 There were significant differences in polypharmacy among patients according to the region where they live, their income, and the health problems they suffered from. 11 The consequences of polypharmacy on patients 4 and the benefits of deprescribing 12 suggest the need to implement deprescribing. However, patients as medication users play a fundamental role in the success of medication cessation process. The revised Patients' Attitudes Towards Deprescribing (rPATD) questionnaire was developed to describe patients' attitude toward deprescribing 13 the rPATD was validated in Arabic; 14 however, context-specific evidence about attitudes towards deprescribing among Saudi patients is limited. This study aimed to assess patients' willingness to deprescribe, and factors associated with medication deprescription in Saudi Ara -Abstract Truncated-
medicine, general & internal